Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × Busulfan × Clear all

Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT04220008 2024-01-12

Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma

Phase 2 Withdrawn

Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01746173 2023-01-30

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Phase 2 Terminated

5 enrolled 7 charts

Lymphoid

Lymphoma, T-Cell

NCT02859402 2022-08-18

RRTCLAlloSCT

Phase 2 Recruiting

34 enrolled

Lymphoid

Recurrence, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell

NCT01181271 2017-03-09

Tandem Auto-Allo Transplant for Lymphoma

Phase 2 Completed

42 enrolled 18 charts

LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Clinical Trials

Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

RRTCLAlloSCT

Tandem Auto-Allo Transplant for Lymphoma